Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC

J Thromb Haemost. 2019 Nov;17(11):1979-1988. doi: 10.1111/jth.14576. Epub 2019 Aug 12.

Bernard Tardy¹, Emilie Chalayer¹, Pieter Willem Kamphuisen², Fionnuala Ni Ainle³, Peter Verhamme⁴, Marie Noelle Varlet⁵, Celine Chauleur⁵, Marc Rodger⁶, Adel Merah¹, Andrea Buchmuller^{1

7

8

9}, Ingrid Bistervels¹⁰, Maria T De Sancho¹¹, Saskia Middeldorp¹⁰, Laurent Bertoletti^{1

7

8

9}; SSC Subcommittee on Control of Anticoagulation of the ISTH

¹ Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France.
² Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands.
³ Department of Haematology, Mater Misericordiae University Hospital Dublin, Dublin, Ireland.
⁴ Vascular Medicine and Haemostasis, University of Leuven, Leuven, Belgium.
⁵ Department of Gynecology and Obstetrics, University Hospital, Saint-Étienne, University Jean-Monnet, Saint-Étienne, France.
⁶ Department of Medicine, Division of Hematology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada.
⁷ Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, St-Etienne, France.
⁸ INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, St-Etienne, France.
⁹ FCRIN-INNOVTE, St-Etienne, France.
¹⁰ Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
¹¹ Department of Medicine, Division of Hematology-Oncology, New York Presbyterian Hospital of Weill Cornell Medical College, New York, NY, USA.

No abstract available

Publication types